Search

Author/Creator Rosing, Hilde

1. A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy. (January 2019)

Authors:
Henricks, Linda M.; Lunenburg, Carin A.T.C.; de Man, Femke M.; Meulendijks, Didier; Frederix, Geert W.J.; Kienhuis, Emma; Creemers, Geert-Jan; Baars, Arnold; Dezentjé, Vincent O.; Imholz, Alexander L.T.; Jeurissen, Frank J.F.; Portielje, Johanna E.A.; Jansen, Rob L.H.; Hamberg, Paul; ten Tije, Al...
Journal:
European journal of cancer
Issue:
Volume 107(2019)
Page Start:
60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir. (November 2017)

Authors:
de Weger, Vincent A.; Stuurman, Frederik E.; Hendrikx, Jeroen J.M.A.; Moes, Johannes J.; Sawicki, Emilia; Huitema, Alwin D.R.; Nuijen, Bastiaan; Thijssen, Bas; Rosing, Hilde; Keessen, Marianne; Mergui-Roelvink, Marja; Beijnen, Jos H.; Schellens, Jan H.M.; Marchetti, Serena
Journal:
European journal of cancer
Issue:
Volume 86(2017)
Page Start:
217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors. Issue 6 (5th October 2020)

Authors:
de Weger, Vincent A.; Vermunt, Marit A.C.; Stuurman, Frederik E.; Burylo, Artur M.; Damoiseaux, David; Hendrikx, Jeroen J.M.A.; Sawicki, Emilia; Moes, Johannes J.; Huitema, Alwin D.R.; Nuijen, Bastiaan; Rosing, Hilde; Mergui‐Roelvink, Marja; Beijnen, Jos H.; Marchetti, Serena
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 6(2021)
Page Start:
607
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children. (June 2023)

Authors:
Nijstad, A Laura; de Vos-Kerkhof, Evelien; Enters-Weijnen, Catherine F; van de Wetering, Marianne D; Tissing, Wim J E; Hanff, Lidwien M; Lange, Rogier; Tibben, Matthijs M; Rosing, Hilde; Lalmohamed, Arief; Zwaan, C Michel; Huitema, Alwin D R
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 29:Number 4(2023)
Page Start:
899
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Capecitabine‐based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency. Issue 2 (30th September 2017)

Authors:
Henricks, Linda M.; Siemerink, Ester J.M.; Rosing, Hilde; Meijer, Judith; Goorden, Susan M.I.; Polstra, Abeltje M.; Zoetekouw, Lida; Cats, Annemieke; Schellens, Jan H.M.; van Kuilenburg, André B.P.
Journal:
International journal of cancer
Issue:
Volume 142:Issue 2(2018)
Page Start:
424
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗